Overview of Avelox 400mg
| Property | Description |
|---|---|
| Active ingredient | Moxifloxacin (as the hydrochloride salt) |
| Form | Tablet (400 mg film-coated) |
| Pharmacological class | Fluoroquinolone Antibiotic |
| Common use | Systemic Bacterial Infections |
| Origin | Synthetic |
What Type of Medicine is Avelox 400mg?
Avelox 400mg is a systemic, prescription-only medicinal product, originally developed by Bayer AG, whose function is defined by its active compound, moxifloxacin. The medication belongs to the Fluoroquinolone class of anti-bacterial agents, placing it within the broader family of Antibiotics. Moxifloxacin is a highly specialized, synthetic compound, chemically synthesized rather than naturally derived. It is categorized as an anti-bacterial agent used in treating microbial disease. This confirms the drug is exclusively for use against bacterial infections, possessing no activity against viral, fungal, or other non-bacterial pathogens.
Composition and Physical Form of Moxifloxacin
The active agent in Avelox 400mg is moxifloxacin, typically presented as the hydrochloride salt, which is integrated into a single active ingredient product. The medication is manufactured as a 400 mg film-coated tablet, representing the oral dosage form intended for systemic use, meaning the substance is absorbed into the bloodstream to act throughout the body. The structure and classification of moxifloxacin define it as a fluoroquinolone. The tablet formulation utilizes solid excipients to ensure stability and proper delivery of the moxifloxacin compound upon ingestion, facilitating a reliable route of administration.
General Purpose: Targeting Bacterial Infections
The general purpose of Avelox is to resolve active infection by clearing the body of susceptible bacteria. It achieves this through a direct bactericidal action, which means the drug actively kills the microorganisms rather than merely slowing their growth. Moxifloxacin is used in systemic applications, such as the treatment of respiratory tract infections. The compound is a broad-spectrum antibiotic, a characteristic indicating its ability to combat a wide variety of Gram-positive and Gram-negative pathogens, thereby establishing its therapeutic intent.
